Description
NDC: 0143-9249-20
Amoxicillin / Clavulanate Potassium 875 mg / 125 mg Tablets, 20 count — Hikma
| Active ingredients | Amoxicillin 875 mg (as trihydrate) and clavulanic acid 125 mg (as potassium salt) per tablet |
| Dosage form | Film-coated, scored oral tablet |
| Route | Oral |
| Size | 20 tablets per bottle |
| Manufacturer | Hikma |
| NDC | 0143-9249-20 |
Indications and Usage
Treatment of beta-lactamase-producing bacterial infections, including lower respiratory tract infections, acute bacterial otitis media, sinusitis, skin and skin-structure infections, and urinary tract infections.
Dosage and Administration
Adults and pediatric patients weighing 40 kg or more: one 875 mg tablet every 12 hours (dosed on the amoxicillin component). Take at the start of a meal to reduce gastrointestinal upset.
Warnings and Precautions
- Serious hypersensitivity and anaphylactic reactions
- Severe cutaneous adverse reactions; discontinue if rash progresses
- Clostridioides difficile-associated diarrhea
- Hepatic dysfunction and cholestatic jaundice; avoid use in mononucleosis
Contraindications
History of a serious hypersensitivity reaction to a penicillin or cephalosporin, or prior cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate.
Adverse Reactions
Most commonly diarrhea or loose stools, nausea, and skin rash or urticaria.
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F) in a tight container.
How Supplied
Supplied as 20 scored, capsule-shaped tablets in a bottle.
Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.
